How Hospitals Use Algorithms to Prioritize Vaccine Distribution
Why it matters: How hospitals use algorithms to prioritize vaccine distribution: scoring systems, Palantir Tiberius, bias risks, and ML models for future pandemics.
AI Insider·
The transformation of healthcare through artificial intelligence is no longer a speculative proposition. It is happening at scale, in hospitals, in living rooms, in clinical trials, and in the benefit packages that hundreds of millions of workers select each year. The CEOs driving this shift are not simply technology founders who saw an opportunity in […]
Read full articleWhy it matters: How hospitals use algorithms to prioritize vaccine distribution: scoring systems, Palantir Tiberius, bias risks, and ML models for future pandemics.
Artificial intelligence is restructuring medicine from the exam room to the lab bench. The companies doing it most consequentially are not just digitizing old workflows — they are replacing the underlying logic of how care gets documented, how drugs get discovered, how patients move through the system, and how clinicians access knowledge. From cardiothoracic imaging to whole-brain […]
For the past decade, artificial intelligence mostly lived on a screen. It answered questions, finished sentences, sorted images, and recommended the next thing to watch. That era is ending. The next wave of AI has hands, wheels, rotors, and sensors — and it’s being asked to operate reliably in warehouses, hospitals, farms, and city streets. […]
Isomorphic Labs raised $2.1B in Series B funding to scale its AI drug design engine, IsoDDE, and move drug candidates into clinical trials.
In “AI for Good,” Josh Tyrangiel talks to the classrooms, hospitals and research labs where people are using artificial intelligence that might benefit society.
When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Do you trust AI chatbots for health advice? What about one in your patient portal?
DeepCyte launches with $1.5M in seed funding to build AI toxicology tools that predict and explain drug toxicity at single-cell resolution.